Mangoceuticals, Common Stock Stock Filter Stocks by Fundamentals
| MGRX Stock | 2.50 0.03 1.19% |
Mangoceuticals, Common Stock fundamentals help investors to digest information that contributes to Mangoceuticals, Common's financial success or failures. It also enables traders to predict the movement of Mangoceuticals, Stock. The fundamental analysis module provides a way to measure Mangoceuticals, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mangoceuticals, Common stock.
Mangoceuticals, |
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Mangoceuticals, Common ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mangoceuticals, Common's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mangoceuticals, Common's managers, analysts, and investors.Environmental | Governance | Social |
Mangoceuticals, Fundamentals
| Return On Equity | -1.08 | ||||
| Return On Asset | -0.58 | ||||
| Operating Margin | (13.05) % | ||||
| Current Valuation | 6.49 M | ||||
| Shares Outstanding | 2.49 M | ||||
| Shares Owned By Insiders | 37.45 % | ||||
| Shares Owned By Institutions | 4.69 % | ||||
| Number Of Shares Shorted | 152.88 K | ||||
| Price To Book | 0.47 X | ||||
| Price To Sales | 7.26 X | ||||
| Revenue | 731.49 K | ||||
| Gross Profit | 4.85 K | ||||
| EBITDA | (9.19 M) | ||||
| Net Income | (9.21 M) | ||||
| Total Debt | 128.68 K | ||||
| Book Value Per Share | 0.54 X | ||||
| Cash Flow From Operations | (7 M) | ||||
| Short Ratio | 0.21 X | ||||
| Earnings Per Share | (5.70) X | ||||
| Market Capitalization | 6.29 M | ||||
| Total Asset | 1.05 M | ||||
| Retained Earnings | (11.23 M) | ||||
| Working Capital | 607.38 K | ||||
| Net Asset | 1.05 M |
About Mangoceuticals, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mangoceuticals, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mangoceuticals, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mangoceuticals, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.